Ligand · CQG
CQG · pyridin-4-ol
CQG, pyridin-4-ol (C5 H5 N O, 95.1 g/mol), in the MolNFT structures on GenesisL1: bound in 10 records (7 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands found with it.
- Component
- CQG
- Formula
- C5 H5 N O
- Class
- ligand
- Structures
- 10
- PDB entries
- 7
Binding sites
CQG in 10 structures; the first of them:
- 6MME · Citrobacter freundii tyrosine phenol-lyase complexed with 4-hydroxypyridine and… · CQG A502 · binds GLN228, ARG323
- 6MO3 · Citrobacter freundii tyrosine phenol-lyase complexed with 4-hydroxypyridine and… · CQG A1601 · binds GLU227, GLN228, ARG323
- 6NV8 · Perdeuterated tyrosine phenol-lyase from Citrobacter freundii complexed with an… · CQG A1002 · binds GLU227, GLN228, ARG323
- 6B4Q · Crystal structure of purine nucleoside phosphorylase isoform 2 from schistosoma mansoni… · CQG A307 · binds LEU118, ALA119, GLY120, TYR202, GLU203, VAL219, GLY220, MET221 and 1 more
- 6MLS · Citrobacter freundii tyrosine phenol-lyase complexed with 4- hydroxypyridine and… · CQG A502 · binds GLN228, ARG323
- 6MME · Citrobacter freundii tyrosine phenol-lyase complexed with 4- hydroxypyridine and… · CQG A502 · binds GLN228, ARG323
- 6MO3 · Citrobacter freundii tyrosine phenol-lyase complexed with 4- hydroxypyridine and… · CQG A1601 · binds GLU227, GLN228, ARG323
- 6MPD · Citrobacter freundii tyrosine phenol-lyase complexed with 4- hydroxypyridine and… · CQG A1002 · binds GLN228, ARG323
- 6MQQ · Citrobacter freundii F448A mutant tyrosine phenol-lyase complexed with 4-hydroxypyridine… · CQG A601 · binds PHE123, THR124, ARG381, PHE449, 0JO603, TYR71
- 6NV8 · Perdeuterated tyrosine phenol-lyase from citrobacter freundii complexed with an… · CQG A1002 · binds GLU227, GLN228, ARG323
Residues it binds most
PHE 9, ARG 18, THR 17, GLU 13, TYR 11, SER 8, VAL 9, 0JO 8, ASP 8, GLN 8 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.